Literature DB >> 29929061

Hypervigilance during anxiety and selective attention during fear: Using steady-state visual evoked potentials (ssVEPs) to disentangle attention mechanisms during predictable and unpredictable threat.

Anna K Kastner-Dorn1, Marta Andreatta1, Paul Pauli1, Matthias J Wieser2.   

Abstract

Anxiety is induced by unpredictable threat, and presumably characterized by enhanced vigilance. In contrast, fear is elicited by imminent threat, and leads to phasic responses with selective attention. In order to investigate attention mechanisms and defensive responding during fear and anxiety, we employed an adaptation of the NPU-threat test and measured cortical (steady-state visual evoked potentials, ssVEPs), physiological (heart rate, HR), and subjective responses (ratings) to predictable (fear-related) and unpredictable (anxiety-related) threat in 42 healthy participants. An aversive unconditioned stimulus (US, loud noise) was 100% predicted by a cue (predictable P-cue) in one context (predictable P-context), but appeared unpredictably within a different context (unpredictable U-context, U-cue), while it was never delivered in a neutral safe context (N-cue, N- context). In response to predictable threat (P-cue), increased ssVEP amplitudes and accelerated HR were found. Both predictable and unpredictable contexts yielded increased ssVEP amplitudes compared to the safe context. Interestingly, in the unpredictable context participants showed longer-lasting visuocortical activation than in the predictable context, supporting the notion of heightened vigilance during anxiety. In parallel, HR decelerated to both threat contexts indicating fear bradycardia to these threatening contexts as compared to the safe context. These results support the idea of hypervigilance in anxiety-like situations reflected in a long-lasting facilitated processing of sensory information, in contrast to increased selective attention to specific imminent threat during fear. Thus, this study further supports the defense-cascade model with vigilance and orienting in the post-encounter phase of threat (anxiety), while selective attention and defensive mobilization in the circa-strike phase of threat (fear).
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Attention; Defensive responding; EEG; Fear; Heart rate; ssVEP

Year:  2018        PMID: 29929061     DOI: 10.1016/j.cortex.2018.05.008

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  6 in total

1.  Cortical mechanisms of visual hypersensitivity in women at risk for chronic pelvic pain.

Authors:  Matthew J Kmiecik; Frank F Tu; Rebecca L Silton; Katlyn E Dillane; Genevieve E Roth; Steven E Harte; Kevin M Hellman
Journal:  Pain       Date:  2021-08-27       Impact factor: 7.926

2.  The 'Threat of Scream' paradigm: a tool for studying sustained physiological and subjective anxiety.

Authors:  Guillaume Dezecache; Julie Grèzes; Morgan Beaurenaut; Elliot Tokarski
Journal:  Sci Rep       Date:  2020-07-27       Impact factor: 4.379

3.  The effect of trait anxiety on attentional mechanisms in combined context and cue conditioning and extinction learning.

Authors:  Yannik Stegmann; Philipp Reicherts; Marta Andreatta; Paul Pauli; Matthias J Wieser
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

4.  Detecting driver stress and hazard anticipation using real-time cardiac measurement: A simulator study.

Authors:  Laora Kerautret; Stephanie Dabic; Jordan Navarro
Journal:  Brain Behav       Date:  2022-01-28       Impact factor: 2.708

5.  The steady state visual evoked potential (SSVEP) tracks "sticky" thinking, but not more general mind-wandering.

Authors:  Hang Yang; Ken A Paller; Marieke van Vugt
Journal:  Front Hum Neurosci       Date:  2022-08-11       Impact factor: 3.473

6.  Early Safety Discrimination Under Uncertainty in Trait Anxiety: An Event-Related Potential Study.

Authors:  Yan Jin; Lei Zhang; Wei Chen; Xifu Zheng
Journal:  Front Hum Neurosci       Date:  2022-06-23       Impact factor: 3.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.